+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a drug therapy in arthritis and rheumatoid conditions

Evaluation of a drug therapy in arthritis and rheumatoid conditions

Journal of the Maine Medical Association 46(4): 99-101

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 048993404

Download citation: RISBibTeXText

PMID: 14368127

Related references

The incidence of rheumatoid arthritis precipitin in rheumatoid arthritis or sjogrens syndrome associated with rheumatoid arthritis and the relationship to drug therapy. Clinical Research 26(1): 25A, 1978

A new form of drug therapy in the treatment of arthritis and rheumatoid conditions. Wisconsin Medical Journal 53(4): 223-225, 1954

Evaluation of drug therapy in rheumatoid arthritis-study of flufenamic acid. Western Medicine; the Medical Journal of the West 4: 228-232, 1963

Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan. Arthritis Care and Research 70(12): 1719-1726, 2018

Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment. Recenti Progressi in Medicina 89(1): 14-17, 1998

Treatment of chronic rheumatoid arthritis. 2. Re-evaluation of gold therapy for rheumatoid arthritis. Ryumachi 13(4): 368, 1973

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Research and Therapy 12(3): R122, 2010

The value of contrast enhanced magnetic resonance imaging in evaluation of drug therapy in rheumatoid arthritis: A prospective study on hand joints in 65 patients. Acta Pharmaceutica Zagreb 43(4): 267-276, 1993

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis and Rheumatism 46(4): 894-898, 2002

An evaluation of phenylbutazone (butazolidin) in the treatment of gout, rheumatoid spondylitis, rheumatoid arthritis and other conditions of the musculoskeletal system. Southern Medical Journal 50(5): 655-662, 1957

FDA Arthritis Advisory Committee Meeting: juvenile rheumatoid arthritis drug evaluation guidelines; over-the-counter naproxen?. Arthritis and Rheumatism 37(1): 137-138, 1994

Drug therapy in rheumatoid arthritis--procedures and standards of drug selection. Nihon Rinsho. Japanese Journal of Clinical Medicine 33(2): 331-335, 1975

Studies on chryso therapy in rheumatoid arthritis part 3 pathogenesis of rheumatoid factor in rheumatoid arthritis and influence of gold salt on rheumatoid factor. Okayama Igakkai Zasshi 88(11-12): 1133-1148, 1976

Evaluation of drug-drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 45(7): 615-624, 2015

Drug-induced changes in chemotaxis under normal conditions and in rheumatoid arthritis. Bollettino Della Societa Italiana di Biologia Sperimentale 58(7): 378-384, 1982